1 |
Cummings J, Feldman HH and Scheltens P (2019) The "rights" of precision drug development for Alzheimer's disease. Alzheimers Res Ther 11, 76
DOI
|
2 |
Wang Y and Cai Y (2016) Obtaining human ischemic stroke gene expression biomarkers from animal models: a cross-species validation study. Sci Rep 6, 29693
DOI
|
3 |
Chaudhuri JD (2000) Blood brain barrier and infection. Med Sci Monit 6, 1213-1222
|
4 |
Kim Y, Stolarska MA and Othmer HG (2011) The role of the microenvironment in tumor growth and invasion. Prog Biophys Mol Biol 106, 353-379
DOI
|
5 |
Ahn SI, Sei YJ, Park HJ et al (2020) Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat Commun 11, 175
DOI
|
6 |
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR and Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37, 13-25
DOI
|
7 |
Abbott NJ, Ronnback L and Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53
DOI
|
8 |
Xia Y and Whitesides GM (1998) Soft lithography. Angew Chem Int Ed Engl 37, 550-575
DOI
|
9 |
Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2, 3-14
DOI
|
10 |
Van Norman GA (2019) Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic Transl Sci 4, 845-854
DOI
|
11 |
De Bock M, Van Haver V, Vandenbroucke RE, Decrock E, Wang N and Leybaert L (2016) Into rather unexplored terrain-transcellular transport across the blood-brain barrier. Glia 64, 1097-1123
DOI
|
12 |
Huber JD, Egleton RD and Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24, 719-725
DOI
|
13 |
Abbott NJ (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36, 437-449
DOI
|
14 |
Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36, 179-194
DOI
|
15 |
Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15, 275-292
DOI
|
16 |
Geldenhuys WJ, Allen DD and Bloomquist JR (2012) Novel models for assessing blood-brain barrier drug permeation. Expert Opin Drug Metab Toxicol 8, 647-653
DOI
|
17 |
Obermeier B, Daneman R and Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19, 1584-1596
DOI
|
18 |
Hajal C, Le Roi B, Kamm RD and Maoz BM (2021) Biology and models of the blood-brain barrier. Annu Rev Biomed Eng 23, 359-384
DOI
|
19 |
Dawson TM, Golde TE and Lagier-Tourenne C (2018) Animal models of neurodegenerative diseases. Nat Neurosci 21, 1370-1379
DOI
|
20 |
Akhtar A (2015) The flaws and human harms of animal experimentation. Camb Q Healthc Ethics 24, 407-419
DOI
|
21 |
Bowman PD, Ennis SR, Rarey KE, Betz AL and Goldstein GW (1983) Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol 14, 396-402
DOI
|
22 |
Rauh J, Meyer J, Beuckmann C and Galla HJ (1992) Development of an in vitro cell culture system to mimic the blood-brain barrier. Prog Brain Res 91, 117-121
DOI
|
23 |
Stone NL, England TJ and O'Sullivan SE (2019) A novel transwell blood brain barrier model using primary human cells. Front Cell Neurosci 13, 230
DOI
|
24 |
Lyu Z, Park J, Kim KM et al (2021) A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke. Nat Biomed Eng 5, 847-863
DOI
|
25 |
Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML and Hickman JJ (2015) TEER measurement techniques for in vitro barrier model systems. J Lab Autom 20, 107-126
DOI
|
26 |
Wang YI, Abaci HE and Shuler ML (2017) Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Biotechnol Bioeng 114, 184-194
DOI
|
27 |
Bhatia SN and Ingber DE (2014) Microfluidic organs-on-chips. Nat Biotechnol 32, 760-772
DOI
|
28 |
Golaszewska A, Bik W, Motyl T and Orzechowski A (2019) Bridging the gap between Alzheimer's disease and Alzheimer's-like diseases in animals. Int J Mol Sci 20, 1664
DOI
|
29 |
Shin Y, Choi SH, Kim E et al (2019) Blood-brain barrier dysfunction in a 3D in vitro model of Alzheimer's disease. Adv Sci (Weinh) 6, 1900962
DOI
|
30 |
Yang C, Hawkins KE, Dore S and Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316, C135-C153
DOI
|
31 |
Kim J, Lee KT, Lee JS et al (2021) Fungal brain infection modelled in a human-neurovascular-unit-on-a-chip with a functional blood-brain barrier. Nat Biomed Eng 5, 830-846
DOI
|
32 |
Kim HN, Habbit NL, Su CY et al (2019) Microphysiological systems as enabling tools for modeling complexity in the tumor microenvironment and accelerating cancer drug development. Adv Funct Mater 29, 1807553
DOI
|
33 |
Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12, 54-61
DOI
|
34 |
Buzhdygan TP, DeOre BJ, Baldwin-Leclair A et al (2020) The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 146, 105131
DOI
|
35 |
Mansour AA, Goncalves JT, Bloyd CW et al (2018) An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol 36, 432-441
DOI
|
36 |
Clevers H (2016) Modeling development and disease with organoids. Cell 165, 1586-1597
DOI
|
37 |
Pham MT, Pollock KM, Rose MD et al (2018) Generation of human vascularized brain organoids. Neuroreport 29, 588-593
DOI
|
38 |
Qian X, Song H and Ming GL (2019) Brain organoids: advances, applications and challenges. Development 146, dev166074
DOI
|
39 |
Shi Y, Sun L, Wang M et al (2020) Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. PLoS Biol 18, e3000705
DOI
|
40 |
Cakir B, Xiang Y, Tanaka Y et al (2019) Engineering of human brain organoids with a functional vascular-like system. Nat Methods 16, 1169-1175
DOI
|
41 |
Wang X, Xu B, Xiang M et al (2020) Advances on fluid shear stress regulating blood-brain barrier. Microvasc Res 128, 103930
DOI
|
42 |
Xiong Y, Mahmood A and Chopp M (2013) Animal models of traumatic brain injury. Nat Rev Neurosci 14, 128-142
DOI
|
43 |
van der Meer AD, Poot AA, Feijen J and Vermes I (2010) Analyzing shear stress-induced alignment of actin filaments in endothelial cells with a microfluidic assay. Biomicrofluidics 4, 11103
DOI
|
44 |
Xu H, Li Z, Yu Y et al (2016) A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors. Sci Rep 6, 36670
DOI
|
45 |
Park TE, Mustafaoglu N, Herland A et al (2019) Hypoxia-enhanced blood-brain barrier chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun 10, 2621
DOI
|
46 |
Rosenberg GA (2012) Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 32, 1139-1151
DOI
|
47 |
Daneman R (2012) The blood-brain barrier in health and disease. Ann Neurol 72, 648-672
DOI
|
48 |
Zhang B, Korolj A, Lai BFL and Radisic M (2018) Advances in organ-on-a-chip engineering. Nat Rev Mater 3, 257-278
DOI
|
49 |
Viravaidya K, Sin A and Shuler ML (2004) Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol Prog 20, 316-323
DOI
|
50 |
Sin A, Chin KC, Jamil MF, Kostov Y, Rao G and Shuler ML (2004) The design and fabrication of three-chamber micro-scale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol Prog 20, 338-345
DOI
|
51 |
Zhang B and Radisic M (2017) Organ-on-a-chip devices advance to market. Lab Chip 17, 2395-2420
DOI
|
52 |
Reardon S (2015) 'Organs-on-chips' go mainstream. Nature 523, 266
DOI
|
53 |
Bang S, Lee SR, Ko J et al (2017) A low permeability microfluidic blood-brain barrier platform with direct contact between perfusable vascular network and astrocytes. Sci Rep 7, 8083
DOI
|
54 |
Urich E, Patsch C, Aigner S, Graf M, Iacone R and Freskgard PO (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep 3, 1500
DOI
|
55 |
Eilenberger C, Rothbauer M, Selinger F et al (2021) A microfluidic multisize spheroid array for multiparametric screening of anticancer drugs and blood-brain barrier transport properties. Adv Sci (Weinh) 8, e2004856
|
56 |
Sweeney MD, Sagare AP and Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14, 133-150
DOI
|
57 |
Drummond E and Wisniewski T (2017) Alzheimer's disease: experimental models and reality. Acta Neuropathol 133, 155-175
DOI
|
58 |
Ma C, Peng Y, Li H and Chen W (2021) Organ-on-a-chip: a new paradigm for drug development. Trends Pharmacol Sci 42, 119-133
DOI
|
59 |
Duffy DC, McDonald JC, Schueller OJ and Whitesides GM (1998) Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 70, 4974-4984
DOI
|
60 |
Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY and Ingber DE (2010) Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668
DOI
|
61 |
Seo S, Nah SY, Lee K, Choi N and Kim HN (2021) Triculture model of in vitro BBB and its application to study BBB-associated chemosensitivity and drug delivery in glioblastoma. Adv Funct Mater 32, 2106860
|
62 |
Cho CF, Wolfe JM, Fadzen CM et al (2017) Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 8, 15623
DOI
|
63 |
Schoknecht K and Shalev H (2012) Blood-brain barrier dysfunction in brain diseases: clinical experience. Epilepsia 53 Suppl 6, 7-13
DOI
|
64 |
Yoon JK, Kim J, Shah Z, Awasthi A, Mahajan A and Kim Y (2021) Advanced human BBB-on-a-chip: a new platform for Alzheimer's disease studies. Adv Healthc Mater 10, e2002285
|